Holding(s) in Company

RNS Number : 3820L
Advanced Medical Solutions Grp PLC
05 May 2010
 



 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

ADVANCED MEDICAL SOLUTIONS GRO

 

2 Reason for the notification (please tick the appropriate box or boxes):

 

An acquisition or disposal of voting rights


X

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


 

An event changing the breakdown of voting rights


 

Other (please specify):

 


 

3. Full name of person(s) subject to the notification obligation:

 

AXA S.A., 25 Avenue Matignon, 75008 Paris and its group of companies

4. Full name of shareholder(s) (if different from 3.):

 


5. Date of the transaction and date on which the threshold is crossed or reached:

 

04/05/2010

6. Date on which issuer notified:

 

05/05/2010

7. Threshold(s) that is/are crossed or reached:

 

11%

 

8. Notified details:

A: Voting rights attached to shares

 

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights

Direct

Direct

Indirect

Direct

Indirect


453659

16,324,054

16,324,054

300,000

300,000

16,024,054

0.20

10.45


 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial
instrument

Expiration
date

Exercise/
Conversion
Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

 

% of voting
rights






 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial
instrument

Exercise
price

Expiration
date

Exercise/
Conversion
period

Number of voting
rights instrument
refers to

% of voting rights

 






Nominal

Delta

 



 

Total (A+B+C)

 

Number of voting rights

Percentage of voting rights


16,324,054


10.64%

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

 

 

Name of the Company/Fund
No. of Shares
% of issued
share capital
 
 
 
AXA IM UK

Direct

 

300,000.00
0.195597
AXA IM UK
 
Indirect
16,024,054.00
10.447527
 
 
Total Direct
Total Indirect
  
 
300,000
16,024,054
 
 
0.19560
10.44753
TOTAL
16,324,054
10.64312

 

Proxy Voting:

 

10. Name of the proxy holder:

 


11. Number of voting rights proxy holder will cease to hold:

 


12. Date on which proxy holder will cease to hold voting rights:

 


 

13. Additional information:

 


14. Contact name:

 

Kyere Tabiri

15. Contact telephone number:

 

020 7003 1510

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUVAURRBAVRAR
UK 100

Latest directors dealings